Caption Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Caption Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100,000	Closed	-$9.29M	–	2140
2021 Q4	$9.29M	Buy	100,000 +70,000	+233%	+$4.61M	0.1%	255
2021 Q3	$1.79M	Sell	30,000 -30,000	-50%	-$1.77M	0.02%	807
2021 Q2	$4.09M	Buy	60,000 +45,000	+300%	+$2.93M	0.05%	425
2021 Q1	$1.04M	Sell	15,000 -15,100	-50%	-$1.16M	0.02%	675
2020 Q4	$2.31M	Buy	30,100 +10,100	+51%	+$757K	0.05%	404
2020 Q3	$1.5M	Buy	+20,000	New	+$1.33M	0.04%	518
2019 Q2	–	Sell	-25,000	Closed	-$1.12M	–	891
2019 Q1	$1.12M	Buy	+25,000	New	+$1.15M	0.06%	336

Caption Management's ARNA Position: Q4 2021 in Review

Caption Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 6,900 shares — an estimated $455K sold.

Caption Management first reported a position in ARNA in Q2 2019 and held it in 3 quarters. The position peaked at $5.84M in Q2 2020. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

Caption Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
Caption Management sold 6,900 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $455K.
Caption Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 3 quarters.
Caption Management's Arena Pharmaceuticals Inc position peaked at $5.84M in Q2 2020.
316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.